Drupal-Bibcite31<style face="normal" font="default" size="100%">A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK</style><style face="normal" font="default" size="100%">A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK</style>